Use the Back button in your browser to see the other results of your search or to select another record.
Effet d'un programme de facilitation proprioceptive neuromusculaire (concept PNF) sur la marcheet sur la force musculairechez des patients hemiparetiques: essai controle randomise (Effect of a proprioceptive neuromuscular facilitation program (PNF concept) on walking and muscle strength in hemiparetic patients: randomized controlled trial) [French] |
Abdelnour N, Maynard L, Dubost J-B, Assi A, Tomb R, Mesure S |
Kinesitherapie La Revue 2022 Jun;22(246):3-11 |
clinical trial |
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Stroke-related functional motor disorders are associated with segmental incoordination and impaired proprioception. The objective is to evaluate the efficacy of proprioceptive neuromuscular facilitation (PNF) techniques on walking by increasing muscle strength and coordination in patients. Two groups of 16 hemiparetic subjects underwent a conventional 30-min training program supplemented by a 30-min PNF program or a conventional segmental muscle training program for 3 weeks (5 times x week). Functionality (Katz scale), gait (TDM6 and 10 m) and isometric hip strength indices were assessed before and after treatment. The results show a significant improvement in the gait and strength parameters (p < 0.05) in the intervention group. The PNF technique allows a better organization of motor coordination as well as a more efficient consideration of proprioceptive information during gait associated with an increase in strength. Studies on the duration of application and the persistence of these gains will need to complement these results. LEVEL OF EVIDENCE: 2.
|